Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

Journal of Clinical Oncology

Volumn 20, Issue 5, 2002, Pages 1375-1382

  Stupp, Roger ^a   Dietrich, Pierre Yves ^a   Kraljevic, Sandrine Ostermann ^a   Pica, Alessia ^a   Maillard, Ivan ^a   Maeder, Phillipe ^a   Meuli, Reto ^a   Janzer, Robert ^a   Pizzolato, Gianpaolo ^a   Miralbell, Raymond ^a   Porchet, François ^a   Regli, Luca ^a   de Tribolet, Nicolas ^a   Mirimanoff, René O ^a   Leyvraz, Serge ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLIOBLASTOMA; HUMAN; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PNEUMOCYSTOSIS; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DACARBAZINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PNEUMOCYSTIS INFECTIONS;

EID: 0036499085     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.5.1375     Document Type: Article

References (33)

1. The new WHO classification of brain tumours
2. Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications
3. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial
4. Combined modality therapy of operated astrocytomas grade III and IV: Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time - A prospective multicenter trial of the Scandinavian Glioblastoma Study Group
5. Neoplasms of the central nervous system
6. Chemotherapy for high-grade gliomas
7. Brain tumors
8. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
9. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A Medical Research Council trial
10. Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials
11. Current and future developments in the use of temozolomide for the treatment of brain tumors
12. Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer
13. Temozolomide and treatment of malignant glioma
14. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
15. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
16. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
17. Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: Comparison of oral, intravenous, and hepatic intra-arterial administration
18. Cerebrospinal fluid levels of temozolomide as a surrogate marker for brain penetration
19. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
20. 6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma
21. Phase I trial of temozolomide using an extended continuous oral schedule
22. In vitro evaluation of temozolomide combined with x-irradiation
23. Survival of human glioma cells treated with various combination of temozolomide and x-rays
24. p53 Effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells
25. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials
26. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: A report using RTOG 90-06
27. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
28. Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507
29. Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme
30. The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed highgrade astrocytoma
31. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas: The Polymer-Brain Tumor Treatment Group
32. Placebo-controlled multicenter double-blind randomized prospective phase III trial of local chemotherapy with biodegradable carmustine implants (Gliadel) in 240 patients with malignant gliomas: Final results